| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tissue Regenix Group plc (LSE: TRX)
TRX Technical Analysis
5
| As on 22nd Oct 2025 TRX STOCK Price closed @ 7.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 36.48 & Strong Sell for SHORT-TERM with Stoploss of 58.32 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TRXSTOCK Price
| Open | 7.25 | Change | Price | % |
| High | 7.30 | 1 Day | 0.00 | 0.00 |
| Low | 7.05 | 1 Week | -0.75 | -9.38 |
| Close | 7.25 | 1 Month | -18.25 | -71.57 |
| Volume | 99248 | 1 Year | -50.25 | -87.39 |
| 52 Week High 60.00 | 52 Week Low 7.25 | ||||
LSE UK Most Active Stocks
| ALBA | 0.02 | 0.00% |
| UKOG | 0.01 | 0.00% |
| ECR | 0.27 | -20.59% |
| BZT | 0.10 | -16.67% |
| MSMN | 0.02 | 0.00% |
| DEMG | 0.02 | -50.00% |
| RBD | 0.07 | 0.00% |
| CLON | 0.02 | 0.00% |
| SMDS | 582.50 | 0.00% |
| DKE | 0.15 | 0.00% |
LSE UK Top Gainers Stocks
LSE UK Top Losers Stocks
| TRX Daily Charts |
TRX Intraday Charts |
Whats New @ Bazaartrend |
TRX Free Analysis |
|
|
TRX Important Levels Intraday
| RESISTANCE | 7.73 |
| RESISTANCE | 7.58 |
| RESISTANCE | 7.48 |
| RESISTANCE | 7.39 |
| SUPPORT | 7.11 |
| SUPPORT | 7.02 |
| SUPPORT | 6.92 |
| SUPPORT | 6.77 |
TRX Forecast January 2026
| 4th UP Forecast | 16.81 |
| 3rd UP Forecast | 13.74 |
| 2nd UP Forecast | 11.85 |
| 1st UP Forecast | 9.95 |
| 1st DOWN Forecast | 4.55 |
| 2nd DOWN Forecast | 2.65 |
| 3rd DOWN Forecast | 0.76 |
| 4th DOWN Forecast | -2.31 |
TRX Weekly Forecast
| 4th UP Forecast | 15.73 |
| 3rd UP Forecast | 13.01 |
| 2nd UP Forecast | 11.33 |
| 1st UP Forecast | 9.65 |
| 1st DOWN Forecast | 4.85 |
| 2nd DOWN Forecast | 3.17 |
| 3rd DOWN Forecast | 1.49 |
| 4th DOWN Forecast | -1.23 |
TRX Forecast2026
| 4th UP Forecast | 116.76 |
| 3rd UP Forecast | 81.64 |
| 2nd UP Forecast | 59.93 |
| 1st UP Forecast | 38.22 |
| 1st DOWN Forecast | -23.72 |
| 2nd DOWN Forecast | -45.43 |
| 3rd DOWN Forecast | -67.14 |
| 4th DOWN Forecast | -102.26 |
Tissue Regenix Group plc ( LSE UK Symbol : TRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TRX Business Profile
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, Cardiac, and GBM-V divisions. The company provides dCELL technology, a soft tissue decellularisation process that removes DNA and cellular material to reduce risk of injection; and BioRinse technology, a natural bone filler solution for osteoinductive to stimulate and regenerate native bone growth. In addition, the company provides DermaPure, a decellularised dermal allograft for orthopaedics, trauma, and woundcare; DermaPure Non-Oriented Decellularised allograft dermal tissue for urogynaecology and general surgery; and SurgiPure XD, Decellularised xenograft dermal tissue for the repair of hernias and/or body wall defects. Further, it offers OrthoPure XT, a scaffold to replace the damaged tissue that will re-populate with the patient's own cells; ConCelltrate 100, a verified osteoinductive bone matrix for orthopaedics and spine; MatrixCellect 100, a demineralised bone matrix (DBM) for orthopaedics, trauma, and spine; Matrix IQ Dermis, a human-derived dermal graft, which is decellularised to remove cellular components and preserve the biological properties that promote revascularisation, repair, and augmentation of damaged tissue; and Matrix OI FlexIt, a thin pliable demineralised cortical allograft bone sheet. Additionally, the company provides DentalFix, a mineralized particulate allograft that offer osteoconductive properties of natural bone; CardioPure product; Matrix OI 100 DBM for spine and non-structural bone-grafting; Matrix OI Strips and Blocks, a cell containment scaffold; AmnioWorks for ophthalmology; and sports medicine products. The company was incorporated in 2006 and is based in Garforth, the United Kingdom. Address: Unit 3, Garforth, United Kingdom, LS25 2GY
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service